PUK16 Reduced Use of Erythropoiesis-Stimulating Agents and Intravenous Iron with Use of the Phosphate Binder Ferric Citrate- a Facility-Level Cost-Offset Model Under the Medicare Bundle
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.836
https://www.valueinhealthjournal.com/article/S1098-3015(12)00901-1/fulltext
Section Title :
Urinary/Kidney Disorders
Section Order :
322
First Page :
A155
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00901-1&doi=10.1016/j.jval.2012.03.836